Phio Pharmaceuticals Corp. Announces Executive and Director Changes
Ticker: PHIO · Form: 8-K · Filed: Jun 12, 2025 · CIK: 1533040
| Field | Detail |
|---|---|
| Company | Phio Pharmaceuticals Corp. (PHIO) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, filing, corporate-governance
TL;DR
Phio Pharma shakes up leadership and exec pay, files financials.
AI Summary
Phio Pharmaceuticals Corp. announced on June 6, 2025, changes in its executive and director roles. The company filed an 8-K report detailing the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its officers. This filing also includes financial statements and exhibits.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in executive and director roles can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Phio Pharmaceuticals Corp. (company) — Registrant
- June 6, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Marlborough, Massachusetts (location) — Principal executive offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for certain officers, though specific names and roles are not detailed in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 6, 2025.
What is the state of incorporation for Phio Pharmaceuticals Corp.?
Phio Pharmaceuticals Corp. is incorporated in Delaware.
Where are Phio Pharmaceuticals Corp.'s principal executive offices located?
The principal executive offices are located at 11 Apex Drive, Suite 300A, PMB 2006, Marlborough, Massachusetts 01752.
What other items are included in this 8-K filing besides executive and director changes?
The filing also includes financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding Phio Pharmaceuticals Corp. (PHIO).